Concepedia

Publication | Open Access

The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: a real‐world experience

DOIFull Paper Access

44

Citations

24

References

2018

Year

Hisham R El‐Khayat, Enas Kamal, Manal H. El‐Sayed, Mortada El‐Shabrawi, Houssein H. Ayoub, Awad Rizk, Mohamed Maher, Reem Y. El Sheemy, Yasser Fouad, Dina Attia
Alimentary Pharmacology & Therapeutics

Abstract

A ledipasvir plus sofosbuvir regimen is well tolerated and effective, and can be used safely in treating adolescent patients with chronic hepatitis C genotype 4.

References

YearCitations

Page 1